Institut de la Vision One of the world's leading research center for vision diseases

The Institut de la Vision tackles both major public health issues in ophthalmology and rarer diseases to bring hope to all those affected by visual impairment. It brings together researchers, doctors, patients and partners to accelerate scientific research into innovative new treatments for the visually impaired.

Discover the Institute

Our patient-focused research strategy

Understanding vision

We analyse all the mechanisms that enable us to see.

Preventing blindness

We develop strategies to preserve vision.

Restoring vision

We open up new therapeutic pathways to restore vision.

Evaluating the benefit

We verify the benefit of our innovations with patients.

The Institute in figures

State-of-the-art technology platforms

Partner countries in 2023

129

Research projects (ongoing)

Active patent families

298

Employees 158 women 140 men

Headlines...

Communication | Research

Parkinson's treatment could delay progression of one form of AMD

Age-related macular degeneration (AMD) is the leading cause of visual impairment in people over 50. Improving treatment options for patients is a major challenge for research. In a new study, a team of researchers from Inserm, CNRS and Sorbonne University at the Institut de la Vision[1] in Paris…

Read the article

Reasons to give to the Institut de la Vision

«We are delighted to be able to support the Institut de la Vision. It's an immense hope for many patients to see the birth of new treatments from which they may one day benefit. Thank you to the Institute for the invaluable work it carries out on a daily basis!»

why support us?